What You Should Know:
– The average price per insulin unit dropped 42%, from $0.33 in 2019 to $0.19, in mid-2024, according to a new report from GoodRx. The drop represent the lowest average recorded…
Continue Reading
Breakthrough in Sleep Apnea Management
The FDA has marked a historic milestone by approving the first pharmaceutical treatment option for certain patients with obstructive sleep apnea. Dr. Sally Seymour, director of the FDA’s division of…
The Unprecedented Rise in Medicaid’s Diabetes Drug Spending
Introduction to the Crisis
Medicaid faces a staggering projection of $29.9 billion in expenditure for type 2 diabetes and weight loss medications, according to a recent report from…
What You Should Know:
– Dexcom, the global leader in continuous glucose monitoring (CGM), has achieved another groundbreaking milestone by launching the first generative AI (GenAI) platform in glucose biosensing technology, Stelo.
– The Stelo platform…
Continue Reading
Western Sydney Diabetes has rolled out a mobile diabetes management application from Taiwan as part of its patient engagement digitisation. A centre led by the Western Sydney Local Health District (WSLHD), WSD has established an…
Continue Reading
What You Should Know:
– Tandem Diabetes Care, an insulin pump manufacturer, has announced expanded compatibility for its t:slim X2™ insulin pump in Canada.
– In-warranty users can now integrate their pumps with both the Dexcom…
Continue Reading
The current healthcare systems in the U.S. often compartmentalize health conditions, treating physical and mental health as distinct entities. This dissociative approach has led to a limited perspective on diabetes treatment focused largely on…
Continue Reading
Introduction
Dexcom, a leader in continuous glucose monitoring (CGM) technology, has revolutionized diabetes management and ventured into broader health and wellness applications. With over 25 years of innovation, the company is forging partnerships and expanding…
Copyright: Julien Behal
What You Should Know:
– Abbott, a global healthcare leader, has officially opened its new global manufacturing center of excellence for Abbott’s diabetes care business in Kilkenny, Ireland.
– Abbott’s FreeStyle Libre portfolio is…
Continue Reading
What You Should Know:
– Abbott announced that its FreeStyle Libre 2 and 3 continuous glucose monitoring (CGM) systems have received FDA clearance for use during common imaging procedures, including X-rays, CT scans, and MRIs.
–…
Continue Reading
